Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dimeticone (Barrier)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Conotrane cream
1302020D0BBAAAC
|
Conotrane | Dimeticone (Barrier) | Skin | 22,032 |
|
Dimeticone 22% / Benzalkonium chloride 0.1% cream
1302020D0AAACAC
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | 1,706 |
|
Siopel cream
1302020D0BEAAAE
|
Siopel | Dimeticone (Barrier) | Skin | 595 |
|
Dimeticone 10% / Cetrimide 0.3% cream
1302020D0AAAEAE
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | 286 |
|
Sprilon aerosol spray
1302020D0BGABAG
|
Sprilon | Dimeticone (Barrier) | Skin | 51 |
|
Cymex cream
1302020D0BFAAA0
|
Cymex (Dimeticone) | Dimeticone (Barrier) | Skin | 18 |
|
Zinc oxide 12.5% / Dimeticone 1.04% spray
1302020D0AAAGAG
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | 15 |
|
Boots Antiseptic Nappy Rash cream
1302020D0BIAAAH
|
Boots (Dimeticone) | Dimeticone (Barrier) | Skin | No data available |
|
Boots Lip & Cold Sore cream
1302020D0BIABA0
|
Boots (Dimeticone) | Dimeticone (Barrier) | Skin | No data available |
|
Dimeticone 10% / Cetrimide 0.5% cream
1302020D0AAAHAH
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | No data available |
|
Dimeticone 10% cream
1302020D0AAAAAA
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | No data available |
|
Generic Vasogen cream
1302020D0AAADAD
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | No data available |
|
Vasogen cream
1302020D0BCAAAD
|
Vasogen | Dimeticone (Barrier) | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.